Related Experiment Video
Updated: Aug 11, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
[The effect of antiprotein plasma on humoral resistance in children with severe burns]
Insights
In severely burned children, key blood markers like alpha 2-macroglobulin and fibronectin decrease during toxemia. Treatment with donor antiproteic plasma shows positive therapeutic effects for burn-related toxic syndromes.
Area of Science:
- Biochemistry
- Pediatric Medicine
- Trauma Care
Context:
- Severely burned children often develop toxemia and septic toxemia.
- The acute phase of these conditions involves significant physiological changes.
- Monitoring specific blood serum components is crucial for assessing disease severity.
Purpose:
- To investigate alterations in specific blood serum components during toxemia in severely burned children.
- To correlate these biochemical changes with the development and progression of toxic syndromes.
- To evaluate the therapeutic efficacy of donor antiproteic plasma.
Summary:
- In severely burned children, decreased anti-triptic activity, alpha 2-macroglobulin, fibronectin, and arginase activity were observed during acute toxemia and septic toxemia.
- Concurrently, there was a significant increase in fibrin-fibrinogen degradation products.
- These alterations in studied indices are informative regarding the toxic syndrome's dynamics.
Impact:
- The findings highlight key biomarkers for monitoring toxic syndrome in pediatric burn patients.
- Understanding these biochemical shifts aids in predicting disease progression.
- Donor antiproteic plasma demonstrates a beneficial therapeutic effect, suggesting its potential role in managing severe burn complications.
Abstract:
In severely burned children, depending on severity of injury, the anti-triptic activity of blood serum, alpha 2-macroglobulin level, fibronectin, activity of an arginase decrease at the acute period of toxemia and septic toxemia. The content of the products of fibrin-fibrinogen degradation increases considerably. Alteration of the indices studied is of informative value and is associated with dynamics of the toxic syndrome development. Use of donor antiproteic plasma has a positive therapeutic effect.
Related Concept Videos
Humoral Immune Responses
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution

